IBI3005

Other Medications

1 Clinical Trials

Description

IBI3005 is an investigational medication currently being studied in clinical trials for various types of advanced solid tumors, including colorectal cancer. It is being evaluated in combination with other cancer therapies. The trials aim to determine the safety and effectiveness of IBI3005 in patients whose cancer has spread or cannot be removed surgically. Specifically in colorectal cancer trials, IBI3005 has been studied in patients whose tumors have specific EGFR mutations. The goal is to see if this combination therapy can shrink tumors or slow their growth.

Mechanism of Action

IBI3005 is being investigated as part of a combination therapy. The specific way IBI3005 works (its molecular target or mechanism of action) is still being characterized in clinical trials. It is being studied alongside other drugs like carboplatin, limertinib, osimertinib, and sintilimab to assess its potential benefit in treating advanced solid tumors.

Side Effects

As IBI3005 is an investigational drug in early-phase trials (Phase 1) The full range of potential side effects is still being evaluated. Safety and tolerability are primary goals of these early trials. Information about specific side effects observed in the trials is not yet widely available But common side effects associated with cancer therapies Especially in combination regimens Can include fatigue Nausea Changes in blood counts And other effects related to the specific drugs being used in the combination.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT07612137 Phase 1
Not yet recruiting
Study of IBI3005 Combination Therapy in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors
China

Quick Info

CategoryOther Medications
Clinical Trials1
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
786 trials
Leucovorin
Other Medications
647 trials
Paclitaxel
Other Medications
54 trials
Trifluridine
Other Medications
50 trials
Cyclophosphamid
Other Medications
50 trials
Cyclophosphamide
Other Medications
49 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.